Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.88 - $5.01 $73,198 - $127,334
25,416 Added 30.7%
108,192 $374,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $23,760 - $43,370
8,137 Added 10.9%
82,776 $242,000
Q1 2024

May 15, 2024

SELL
$3.27 - $5.65 $101,526 - $175,421
-31,048 Reduced 29.38%
74,639 $421,000
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $191,284 - $419,532
92,408 Added 695.9%
105,687 $453,000
Q3 2023

Nov 14, 2023

SELL
$3.29 - $4.9 $436,527 - $650,146
-132,683 Reduced 90.9%
13,279 $46,000
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $620,338 - $858,256
145,962 New
145,962 $678,000
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $94,961 - $141,828
17,553 New
17,553 $141,000
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $403,944 - $533,663
-22,404 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$20.29 - $27.54 $454,577 - $617,006
22,404 New
22,404 $510,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $92.3M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.